CompanyDrug

Novartis’ Remibrutinib Meets Milestones in Late-Stage Chronic Spontaneous Urticaria Studies

CompanyDeals

CStone Pharmaceuticals Enters Licensing Agreement with Allist Pharmaceuticals for Gavreto in China

CompanyDrug

Roche’s Lymphoma Therapy Columvi Receives NMPA Approval for Adult Patients with Relapsed DLBCL

CompanyDeals

Eccogene Secures Exclusive Licensing Deal with AstraZeneca for GLP-1 Agonist ECC5004

Company

Sandoz Enters Euro Debt Market with $2.1 Billion Eurobond Issuance

CompanyDrug

Janssen Presents Real-World Data on Tremfya’s Efficacy in Treatment-Resistant Psoriatic Arthritis

CompanyDeals

Zhejiang Boner Medical Secures Over RMB 800 Million in Pre-IPO Financing for Strategic Expansion

CompanyDrug

ImmuneOnco Biopharmaceuticals’ Timdarpacept (IMM01) Earns Orphan Drug Designation for CMML

CompanyMedical Device

Lifetech Scientific Corporation Receives NMPA Approval for Peripheral Thrombus Suction Catheter

Company

Bayer’s Q3 2023 Financial Report: A Mixed Bag with Consumer Health Driving Growth

Company

Viatris Inc. Reports Q3 2023 Global Net Sales Growth of 1% and Highlights from Earnings Call

CompanyDrug

Abbisko Therapeutics’ CD73 Inhibitor ABSK051 Clears for Phase I Clinical Trial in China